• 제목/요약/키워드: N-glycosylation

검색결과 150건 처리시간 0.031초

Structure-Based Insight on the Mechanism of N-Glycosylation Inhibition by Tunicamycin

  • Danbi Yoon;Ju Heun Moon;Anna Cho;Hyejoon Boo;Jeong Seok Cha;Yoonji Lee;Jiho Yoo
    • Molecules and Cells
    • /
    • 제46권6호
    • /
    • pp.337-344
    • /
    • 2023
  • N-glycosylation, a common post-translational modification, is widely acknowledged to have a significant effect on protein stability and folding. N-glycosylation is a complex process that occurs in the endoplasmic reticulum (ER) and requires the participation of multiple enzymes. GlcNAc-1-P-transferase (GPT) is essential for initiating N-glycosylation in the ER. Tunicamycin is a natural product that inhibits N-glycosylation and produces ER stress, and thus it is utilized in research. The molecular mechanism by which GPT triggers N-glycosylation is discussed in this review based on the GPT structure. Based on the structure of the GPT-tunicamycin complex, we also discuss how tunicamycin reduces GPT activity, which prevents N-glycosylation. This review will be highly useful for understanding the role of GPT in the N-glycosylation of proteins, as well as presents a potential for considering tunicamycin as an antibiotic treatment.

나노 액체크로마토그래피-텐덤 질량분석기를 이용하여 N-당질화 위치 및 N-당사슬 구조 규명을 위한 방법 (A Sensitive Method for Identification of N-Glycosylation Sites and the Structures of N-Glycans Using Nano-LC-MS/MS)

  • 조영은;김숙경;백문창
    • 약학회지
    • /
    • 제57권4호
    • /
    • pp.250-257
    • /
    • 2013
  • Biosimilars are important drugs in medicine and contain many glycosylated proteins. Thorough analysis of the glycosylated protein is a prerequisite for evaluation of biosimilar glycan drugs. A method to assess the diversity of N-glycosylation sites and N-glycans from biosimilar glycan drugs has been developed using two separate methods, LC-MS/MS and MALDI-TOF MS, respectively. Development of sensitive, accurate, and efficient methods for evaluation of glycoproteins is still needed. In this study, analysis of both N-glycosylation sites and N-glycans of glycoprotein was performed using the same LC-MS/MS with two different nano-LC columns, nano-C18 and nano-porous graphitized carbon (nano-PGC) columns. N-glycosylated proteins, including RNAse B (one N-glycosylation site), Fetuin (three sites), and ${\alpha}$-1 acid glycoprotein (four sites), were used, and small amounts of each protein were used for identification of N-glycosylation sites. In addition, high mannose N-glycans (one type of typical glycan structure), Mannose 5 and 9, eluted from RNAse B, were successfully identified using nano-PGC-LC MS/MS analysis, and the abundance of each glycan from the glycoprotein was calculated. This study demonstrated an accurate and efficient method for determination of N-glycosylation sites and N-glycans of glycoproteins based on high sensitive LC-MS/MS using two different nano-columns; this method could be applied for evaluation of the quality of various biosimilar drugs containing N-glycosylation groups.

Mass Spectrometry in the Determination of Glycosylation Site and N-Glycan Structures of Human Placental Alkaline Phosphatase

  • Solakyildirim, Kemal;Li, Lingyun;Linhardt, Robert J.
    • Mass Spectrometry Letters
    • /
    • 제9권3호
    • /
    • pp.67-72
    • /
    • 2018
  • Alkaline phosphatase (AP) is a membrane-bound glycoprotein that is widely distributed in the plasma membrane of cells of various organs and also found in many organisms from bacteria to humans. The complete amino acid sequence and three-dimensional structure of human placental alkaline phosphatase have been reported. Based on the literature data, AP consists of two presumptive glycosylation sites, at Asn-144 and Asn-271. However, it only contains a single occupied N-linked glycosylation site and no occupied O-linked glycosylation sites. Hydrophilic interaction chromatography (HILIC) has been primarily employed for the characterization of the glycan structures derived from glycoproteins. N-glycan structures from human placental alkaline phosphatase (PLAP) were investigated using HILIC-Orbitrap MS, and subsequent data processing and glycan assignment software. 16 structures including 10 sialylated N-glycans were identified from PLAP.

In Vitro Glycosylation of Peptide (RKDVY) and RNase A by PNGase F

  • Park, Su-Jin;Lee, Ji-Youn;Park, Tai-Hyun
    • Journal of Microbiology and Biotechnology
    • /
    • 제13권2호
    • /
    • pp.191-195
    • /
    • 2003
  • The in vitro glycosylation of pentapeptide (Arg-Lys-Asp-Val-Tyr; RKDVY) and RNase A was carried out using PNGase F (peptide-N-glycosidase F), and the results were analyzed using MALDI-TOF-MS. Aminated N,N-diretyl chitobiose was used as the sugar in the glycosylation reaction, and the amination yield of N,N'-diacetyl chitobiose was about $60\%$. To reduce the water activity and shift the reaction equilibrium to a reverse reaction, 1,4-dioxane or ethylene glycol was used as the organic solvent in the enzymatic glycosylation. A certain extent of nonenzymatic glycosylaton, known as the Maillard reaction, was also observed, which occurs on an arginine or lysine residue when the length of tie sugar residue is one or two. However, the extent of glycosylation was much higher in the enzymatic reaction, indicating that PNGase F can be effectively used to produce glycopeptides and glycoproteins in vitro.

Glyco-engineering of Biotherapeutic Proteins in Plants

  • Ko, Kisung;Ahn, Mi-Hyun;Song, Mira;Choo, Young-Kug;Kim, Hyun Soon;Ko, Kinarm;Joung, Hyouk
    • Molecules and Cells
    • /
    • 제25권4호
    • /
    • pp.494-503
    • /
    • 2008
  • Many therapeutic glycoproteins have been successfully generated in plants. Plants have advantages regarding practical and economic concerns, and safety of protein production over other existing systems. However, plants are not ideal expression systems for the production of biopharmaceutical proteins, due to the fact that they are incapable of the authentic human N-glycosylation process. The majority of therapeutic proteins are glycoproteins which harbor N-glycans, which are often essential for their stability, folding, and biological activity. Thus, several glyco-engineering strategies have emerged for the tailor-making of N-glycosylation in plants, including glycoprotein subcellular targeting, the inhibition of plant specific glycosyltranferases, or the addition of human specific glycosyltransferases. This article focuses on plant N-glycosylation structure, glycosylation variation in plant cell, plant expression system of glycoproteins, and impact of glycosylation on immunological function. Furthermore, plant glyco-engineering techniques currently being developed to overcome the limitations of plant expression systems in the production of therapeutic glycoproteins will be discussed in this review.

hEPO 당쇄부위 돌연변이체 제작 및 CHO 세포로부터 변이 단백질의 생산

  • 이풍연;이현기;정희경;이연근;민관식;장원경;이훈택
    • 한국동물번식학회:학술대회논문집
    • /
    • 한국동물번식학회 2002년도 춘계학술발표대회 발표논문초록집
    • /
    • pp.21-21
    • /
    • 2002
  • 사람의 erythropoietin (hEPO) 는 산성 당단백질 호르몬이며 적혈구 생산의 주요조절인자로서 적혈구의 분화와 hemoglobin (Hb) 형성을 촉진하여 빈혈치료제로 이용된다. 사람 EPO 는 166개 아미노산으로 구성되어 있으며, 24, 38, 83 번 아미노산은 N-glycosylation에 의해, 126 번 아미노산은 O-glycosylation에 의해 변형되며, 특히 N-glycosylation은 hEPO 의 세포외 분비 및 활성에 관여한다고 보고된 바 있다. (중략)

  • PDF

The Binding Properties of Glycosylated and Non- Glycosylated Tim-3 Molecules on $CD4^+CD25^+$T Cells

  • Lee, Mi-Jin;Heo, Yoo-Mi;Hong, Seung-Ho;Kim, Kyong-Min;Park, Sun
    • IMMUNE NETWORK
    • /
    • 제9권2호
    • /
    • pp.58-63
    • /
    • 2009
  • Background: T cell immunoglobulin and mucin domain containing 3 protein (Tim-3) expressed on terminally differentiated Th1 cells plays a suppressive role in Th1-mediated immune responses. Recently, it has been shown that N-glycosylation affects the binding activity of the Tim-3-Ig fusion protein to its ligand, galectin-9, but the binding properties of non-glycosylated Tim-3 on $CD4^+CD25^+$T cells has not been fully examined. In this study, we produced recombinant Tim-3-Ig fusion proteins in different cellular sources and its N-glycosylation mutant forms to evaluate their binding activities to $CD4^+CD25^+$T cells. Methods: We isolated and cloned Tim-3 cDNA from BALB/C mouse splenocytes. Then, we constructed a mammalian expression vector and a prokaryotic expression vector for the Tim-3-Ig fusion protein. Using a site directed mutagenesis method, plasmid vectors for Tim-3-Ig N-glycosylation mutant expression were produced. The recombinant protein was purified by protein A sepharose column chromatography. The binding activity of Tim-3-Ig fusion protein to $CD4^+CD25^+$T cells was analyzed using flow cytometry. Results: We found that the nonglycosylated Tim-3-Ig fusion proteins expressed in bacteria bound to $CD4^+CD25^+$T cells similarly to the glycosylated Tim-3-Ig protein produced in CHO cells. Further, three N-glycosylation mutant forms (N53Q, N100Q, N53/100Q) of Tim-3-Ig showed similar binding activities to those of wild type glycosylated Tim-3-Ig. Conclusion: Our results suggest that N-glycosylation of Tim-3 may not affect its binding activity to ligands expressed on $CD4^+CD25^+$T cells.

Exploring the Nucleophilic N- and S-Glycosylation Capacity of Bacillus licheniformis YjiC Enzyme

  • Bashyal, Puspalata;Thapa, Samir Bahadur;Kim, Tae-Su;Pandey, Ramesh Prasad;Sohng, Jae Kyung
    • Journal of Microbiology and Biotechnology
    • /
    • 제30권7호
    • /
    • pp.1092-1096
    • /
    • 2020
  • YjiC, a glycosyltransferase from Bacillus licheniformis, is a well-known versatile enzyme for glycosylation of diverse substrates. Although a number of O-glycosylated products have been produced using YjiC, no report has been updated for nucleophilic N-, S-, and C- glycosylation. Here, we report the additional functional capacity of YjiC for nucleophilic N- and S- glycosylation using a broad substrate spectrum including UDP-α-D-glucose, UDP-N-acetyl glucosamine, UDP-N-acetylgalactosamine, UDP-α-D-glucuronic acid, TDP-α-L-rhamnose, TDP-α-D-viosamine, and GDP-α-L-fucose as donor and various amine and thiol groups containing natural products as acceptor substrates. The results revealed YjiC as a promiscuous enzyme for conjugating diverse sugars at amine and thiol functional groups of small molecules applicable for generating glycofunctionalized chemical diversity libraries. The glycosylated products were analyzed using HPLC and LC/MS and compared with previous reports.

Role of a Putative N-Glycosylation Site in Bovine Retinal Cyclic Nucleotide-Gated Channel

  • Park, Seong-Hwan;Park, Chul-Seung
    • 한국생물물리학회:학술대회논문집
    • /
    • 한국생물물리학회 1997년도 학술발표회
    • /
    • pp.25-25
    • /
    • 1997
  • Cyclic nucleotide-gated channels (CNGC's) contain a putative N-glycosylation site (Asn-X-Ser/Thr) in the linker regions connecting the fourth transmembrane domain (S4) and the ion conduction pore (P-region). This putative N-glycosylation site is highly conserved and thus found in many different CNGC in various organisms, from fruit to human.(omitted)

  • PDF

pH 감응형 나노입자를 이용한 멜라닌 합성저해 연구 (Inhibition of Melanin Synthesis by Enhanced Cytosolic Delivery of N-glycosylation Inhibitors Using pH-Sensitive Nano-carrier)

  • Park, Ju-Young;Park, Hyun-Jung;Shim, Jong-Won;Ahn, Soo-Mi;Kim, Junoh;Chang, Ih-Seop
    • 대한화장품학회지
    • /
    • 제30권1호
    • /
    • pp.29-32
    • /
    • 2004
  • 내형질 세망 조직에서 N-글리코실레이션 과정의 초기 단계를 차단하면 멜라닌 생 합성의 주 효소인 티로시나제의 활성이 저해된다. 본 연구에서는 in vitro 환경에서 N-글리코실레이션 저해제의 활성을 증가시키고자 전달체로 pH 감응성을 갖는 나노크기의 지질구조체를 제조하고 이를 평가하였다. 이 pH 감응성 지질구조체 Melexsome은 일반적인 지질성분인 포스포리피드와 콜레스테롤 기반의 지질안정 성분으로 구성되며, 통상적인 리포좀 제조법에 따라 제조되었다. 글리코실레이션 저해 성분물질을 포집시킨 Melel[some의 효과는 EndoH & PNGaseF 분해와 western blotting 방법에 의해 평가하였고, 멜라닌 합성량 또한 측정 되었다. 이 결과, pH 감응성을 갖도록 제조된 Melexsome이 N-글리코실레이션 저해제의 효능을 효과적으로 증진시킴을 알 수 있었다. 또한, 공초점 주사 현미경에 의한 세포관찰 결과에 따르면 Melexsome은 여타의 전달체에 비하여 세포질 내에 보다 효과적으로 전달되는 것으로 보여지며, 따라서 이같은 양친성 지실성분 기반의 pH 감응성 나노 전달체는 N-글리코실레이션 저해제의 전달 시스템으로서 미백 화장료 제품이 가져야 하는 침착된 색소에 의해 어두워진 피부톤의 개선 효과를 극대화 시키는데 적합하다고 여겨진다.